Enter assignee name

EPO Patents = 1

Forward Citations = 26

Loading Chart...

9 inventors (with patents filed for the assignee):

Patrick Y Lu (6 out of 20 patents)

Martin Woodle (6 out of 7 patents)

Yijia Liu (6 out of 6 patents)

4. Frank Y Xie (6 out of 6 patents)

5. Jun Xu (1 out of 30 patents)

6. Quinn Q Tang (1 out of 1 patent)

7. Samuel Zalipsky (43 patents)

8. Daniel E Levy (0 patent)

6 patents: Sort by Forward Citations

1. 7893244 - Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases (2011-02-22),

2. 7893243 - Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases (2011-02-22),

3. 7786092 - Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases (2010-08-31),

4. 7781414 - Targets for tumor growth inhibition (2010-08-24),

5. 7723316 - Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases (2010-05-25),

6. 7534878 - Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases (2009-05-19),

Intradigm Corporation is a biotechnology company focused on developing novel RNA interference therapeutics for the treatment of cancer and other diseases. Their proprietary technology platform enables the targeted delivery of RNA-based therapies to specific cells, providing a more effective and less toxic approach to treatment. Intradigm is dedicated to advancing the field of RNA interference and improving patient outcomes through innovative drug development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#276 in Palo Alto, CA

#10,282 in California

#43,751 in US

Palo Alto, CA, United States of America

Intradigm Corporation